Carcinoma of Unknown Primary: Improved Ways to Manage Patients
In cases of carcinoma of unknown primary (CUP), the initial goal is to identify the occult tumor so patients have the best oncologic outcome and minimize treatment-related side effects. A retrospective study showed that transoral robotic surgery (TORS) successfully detected the occult malignancy for 80 percent of patients. Many of these patients were subsequently able to forgo radiation (25 percent) and/or chemotherapy (67 percent).
In this white paper, Dr. Kyle Hatten, Assistant Professor of Otorhinolaryngology and Director of Robotic Surgery in the Department of Otorhinolaryngology at the University of Maryland School of Medicine, explains how TORS improves both the diagnosis and treatment of CUP.
For more information about transoral robotic surgery for carcinoma of unknown primary, or to refer a patient, call 410-328-6866.
- Robotic Surgery for Head and Neck Cancer
- ENT Faculty Expand Services and Research
- Head and Neck Mucosal Primary Cancer Clinical Trial: 1685GCC: Phase II/III Randomized Trial of Intensity-Modulated Proton Beam Therapy (IMPT) versus Intensity-Modulated Photon Therapy (IMRT) for the Treatment of Oropharyngeal Cancer of the Head and Neck